{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:13:35Z","timestamp":1790993615730,"version":"4.1.0"},"reference-count":136,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1590\/abd1806-4841.20142573","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:26:20Z","timestamp":1402964780000},"page":"461-470","source":"Crossref","is-referenced-by-count":50,"title":["Vitiligo - Part 1"],"prefix":"10.1590","volume":"89","author":[{"given":"Roberto Gomes","family":"Tarl\u00e9","sequence":"first","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Brazil; Santa Casa de Miseric\u00f3rdia de Curitiba Hospital, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane Machado do","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo T\u00e1vora","family":"Mira","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Cesar Silva de","family":"Castro","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Brazil; Santa Casa de Miseric\u00f3rdia de Curitiba Hospital, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"162","article-title":"Hypoacusis in vitiligo","volume":"70","author":"Sharma L","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0161-6420(79)35413-6","article-title":"Ocular abnormalities occurring with vitiligo","volume":"86","author":"Albert DM","year":"1979","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0190-9622(89)80327-5","article-title":"Audiologic disturbances in vitiligo","volume":"21","author":"Orecchia G","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1001\/archderm.1978.01640210075025","article-title":"Personal responses of patients to vitiligo: the importance of the patient-physician interaction","volume":"114","author":"Porter J","year":"1978","journal-title":"Arch Dermatol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(86)70160-6","article-title":"Psychosocial effect of vitiligo: a comparison of vitiligo patients with \"normal\" control subjects, with psoriasis patients, and with patients with other pigmentary disorders","volume":"15","author":"Porter JR","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2133.2009.09091.x","article-title":"Willingness-to-pay and quality of life in patients with vitiligo","volume":"161","author":"Radtke MA","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-4632.2007.03195.x","article-title":"Vitiligo: the historical curse of depigmentation","volume":"46","author":"Millington GW","year":"2007","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0190-9622(82)70010-6","article-title":"Tzaraat--\"biblical leprosy\"","volume":"6","author":"Freilich AR","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0738-081X(97)00124-7","article-title":"Historical aspects and definition of vitiligo","volume":"15","author":"Kopera D","year":"1997","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archderm.1993.01680290066010","article-title":"Pattern of familial aggregation of vitiligo","volume":"129","author":"Majumder PP","year":"1993","journal-title":"Arch Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb A","year":"2003","journal-title":"Pigment Cell Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/gepi.1370020107","article-title":"Studies on vitiligo. I. Epidemiological profile in Calcutta, India","volume":"2","author":"Das SK","year":"1985","journal-title":"Genet Epidemiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2011.09.011","article-title":"A pattern of association between clinical form of vitiligo and disease-related variables in a Brazilian population","volume":"65","author":"Silva de Castro CC","year":"2012","journal-title":"J Dermatol Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-4632.2006.02848.x","article-title":"Vitiligo prevalence study in Shaanxi Province, China","volume":"46","author":"Lu T","year":"2007","journal-title":"Int J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-4362.2000.00880.x","article-title":"Epidemiology of vitiligo in the French West Indies (Isle of Martinique)","volume":"39","author":"Boisseau-Garsaud AM","year":"2000","journal-title":"Int J Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz J","year":"1977","journal-title":"Arch Dermatol"},{"issue":"2","key":"ref17","first-page":"285","article-title":"Vitiligo","volume":"32","author":"Lerner AB","year":"1959","journal-title":"J Invest Dermatol"},{"key":"ref18","first-page":"145","article-title":"Epidemiological study of vitiligo in Surat area, South Gujarat","volume":"61","author":"Mehta NR","year":"1973","journal-title":"Indian J Med Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000249197","article-title":"Long-term actinic damage in sun-exposed vitiligo and normally pigmented skin","volume":"174","author":"Calanchini-Postizzi E","year":"1987","journal-title":"Dermatologica"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1600-0625.2003.00084.x","article-title":"Increased epidermal functioning wild-type p53 expression in vitiligo","volume":"12","author":"Schallreuter KU","year":"2003","journal-title":"Exp Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2229-5178.101812","article-title":"Immunohistochemical detection of P53 and Mdm2 in vitiligo","volume":"3","author":"Bakry OA","year":"2012","journal-title":"Indian Dermatol Online J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000057881","article-title":"Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed caucasian patients with vitiligo","volume":"204","author":"Schallreuter KU","year":"2002","journal-title":"Dermatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2133.2003.05539.x","article-title":"Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin","volume":"149","author":"Le Poole IC","year":"2003","journal-title":"Br J Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jaad.2008.09.033","article-title":"Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo","volume":"60","author":"Hexsel CL","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjd.12111","article-title":"Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners","volume":"168","author":"Teulings HE","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","article-title":"Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo","volume":"18","author":"Laberge G","year":"2005","journal-title":"Pigment Cell Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","volume":"21","author":"Rezaei N","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0738-081X(97)00125-9","article-title":"Pathophysiology of vitiligo","volume":"15","author":"Castanet J","year":"1997","journal-title":"Clin Dermatol"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"191S","DOI":"10.1038\/jid.1993.75","article-title":"Influence of inflammatory mediators and cytokines on human melanocyte function","volume":"100","author":"Morelli JG","year":"1993","journal-title":"J Invest Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","article-title":"A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?","volume":"16","author":"Gauthier Y","year":"2003","journal-title":"Pigment Cell Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0749.2006.00333.x","article-title":"A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Dell'anna ML","year":"2006","journal-title":"Pigment Cell Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","article-title":"Vitiligo: a manifestation of apoptosis?","volume":"3","author":"Huang CL","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","article-title":"Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis","volume":"74","author":"Spritz RA","year":"2004","journal-title":"Am J Hum Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1086\/430279","article-title":"A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families","volume":"76","author":"Chen JJ","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/sj.jid.5700904","article-title":"Evidence for Two Susceptibility Loci on Chromosomes 22q12 and 6p21-p22 in Chinese Generalized Vitiligo Families","volume":"127","author":"Liang Y","year":"2007","journal-title":"J Invest Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin Y","year":"2007","journal-title":"N Engl J Med"},{"key":"ref37","article-title":"Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo","volume":"5","author":"Ren Y","year":"2009","journal-title":"PLoS Genet"},{"key":"ref38","first-page":"981","article-title":"Genetic epidemiology of vitiligo: multilocus recessivity cross-validated","volume":"55","author":"Nath SK","year":"1994","journal-title":"Am J Hum Genet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1159\/000152448","article-title":"A general model for the genetic analysis of pedigree data","volume":"21","author":"Elston RC","year":"1971","journal-title":"Hum Hered"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00439-002-0687-5","article-title":"Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA","volume":"110","author":"Arcos-Burgos M","year":"2002","journal-title":"Hum Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaad.2003.12.044","article-title":"Characteristics of genetic epidemiology and genetic models for vitiligo","volume":"51","author":"Zhang XJ","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"5181","key":"ref42","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1126\/science.8091226","article-title":"Genetic dissection of complex traits","volume":"265","author":"Lander ES","year":"1994","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/324470","article-title":"Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus","volume":"69","author":"Nath SK","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/11.6.661","article-title":"Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2","volume":"11","author":"Alkhateeb A","year":"2002","journal-title":"Hum Mol Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1086\/375451","article-title":"A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci","volume":"72","author":"Fain PR","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(05)67424-7","article-title":"Genetic association studies","volume":"366","author":"Cordell HJ","year":"2005","journal-title":"Lancet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jid.2010.337","article-title":"Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP","volume":"131","author":"Birlea SA","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1034\/j.1600-0749.2002.00057.x","article-title":"Genetic association of the catalase gene (CAT) with vitiligo susceptibility","volume":"15","author":"Casp CB","year":"2002","journal-title":"Pigment Cell Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1038\/jid.2010.192","article-title":"Promoter variant in the catalase gene is associated with vitiligo in Chinese people","volume":"130","author":"Liu L","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0749.2007.00406.x","article-title":"Association of catalase T\/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population","volume":"20","author":"Em S","year":"2007","journal-title":"Pigment Cell Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1755-148X.2009.00543.x","article-title":"CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data","volume":"22","author":"Birlea SA","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2133.1999.02610.x","article-title":"Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo","volume":"140","author":"Kemp EH","year":"1999","journal-title":"Br J Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0019-5154.60347","article-title":"CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population","volume":"55","author":"Deeba F","year":"2010","journal-title":"Indian J Dermatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0749.2004.00141.x","article-title":"Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population","volume":"17","author":"Tastan HB","year":"2004","journal-title":"Pigment Cell Res"},{"key":"ref55","first-page":"13","article-title":"Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo","volume":"8","author":"Buc M","year":"1998","journal-title":"Eur J Dermatol"},{"key":"ref56","first-page":"221","article-title":"ssociation of HLA class I and II alleles with generalized vitiligo in Chinese Hans in north China","volume":"24","author":"Wang J","year":"2007","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/jid.2011.240","article-title":"HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo","volume":"132","author":"Singh A","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1468-3083.2010.03971.x","article-title":"Comparisons of clinical features of HLA-DRB1*07 positive and negative vitiligo patients in Chinese Han population","volume":"25","author":"Hu DY","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/sj.jid.5700953","article-title":"Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population","volume":"127","author":"Jin Y","year":"2007","journal-title":"J Invest Dermatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00403-010-1064-1","article-title":"Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs","volume":"302","author":"Alkhateeb A","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/jid.2010.34","article-title":"Genetic variants of the DDR1 gene are associated with vitiligo in two independent Brazilian population samples","volume":"130","author":"Silva de Castro CC","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1684\/ejd.2010.0853","article-title":"Association between polymorphisms of discoidin domain receptor tyrosine kinase 1 (DDR1) and non-segmental vitiligo in the Korean population","volume":"20","author":"Kim HJ","year":"2010","journal-title":"Eur J Dermatol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0625.2012.01473.x","article-title":"Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin","volume":"21","author":"Ricard AS","year":"2012","journal-title":"Exp Dermatol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jdv.12013","article-title":"Reduced immunohistochemical expression of Discoidin Domain Receptor 1 (DDR1) in vitiligo skin","volume":"27","author":"Reichert-Faria A","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/jid.2009.347","article-title":"Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8","volume":"130","author":"Birlea SA","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin Y","year":"2010","journal-title":"N Engl J Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ng.603","article-title":"Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC","volume":"42","author":"Quan C","year":"2010","journal-title":"Nat Genet"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/jid.2012.320","article-title":"Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population","volume":"133","author":"Tang XF","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz M","year":"2011","journal-title":"Autoimmun Rev"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0625.2007.00666.x","article-title":"Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?","volume":"17","author":"Schallreuter KU","year":"2008","journal-title":"Exp Dermatol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.1977.tb05188.x","article-title":"A double-blind trial of 0-05% clobetasol proprionate in the treatment of vitiligo","volume":"96","author":"Clayton R","year":"1977","journal-title":"Br J Dermatol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000247164","article-title":"Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patient","volume":"188","author":"Schallreuter KU","year":"1994","journal-title":"Dermatology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2133.1994.tb02910.x","article-title":"British Photodermatology Group guidelines for PUVA","volume":"130","year":"1994","journal-title":"Br J Dermatol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim SM","year":"1999","journal-title":"Int J Dermatol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan S","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1067\/mjd.2002.120576","article-title":"Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well","volume":"46","author":"Cockayne SE","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0923-1811(93)90039-R","article-title":"The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients","volume":"6","author":"Hann SK","year":"1993","journal-title":"J Dermatol Sci"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00403-008-0900-z","article-title":"The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients","volume":"301","author":"Zhang Z","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2133.2012.11198.x","article-title":"The prevalence of thyroid disease in patients with vitiligo: a systematic review","volume":"167","author":"Vrijman C","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.1997.4781381.x","article-title":"Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2)","volume":"109","author":"Kemp EH","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp EH","year":"1998","journal-title":"Br J Dermatol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2249.2001.01516.x","article-title":"Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo","volume":"124","author":"Kemp EH","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp EH","year":"2002","journal-title":"J Clin Invest"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinaserelated protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto T","year":"1998","journal-title":"J Invest Dermatol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients","volume":"7","author":"Bystryn JC","year":"1989","journal-title":"Clin Dermatol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000131485","article-title":"Autoimmune etiology of generalized vitiligo","volume":"10","author":"Le Poole IC","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.0022-202X.2004.23538.x","article-title":"Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo","volume":"124","author":"Steitz J","year":"2005","journal-title":"J Invest Dermatol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","article-title":"Therapeutic implications of autoimmune vitiligo T cells","volume":"5","author":"Oyarbide-Valencia K","year":"2006","journal-title":"Autoimmun Rev"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"van den Wijngaard R","year":"2000","journal-title":"Lab Invest"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1087-0024.2004.00825.x","article-title":"Autoimmune aspects of depigmentation in vitiligo","volume":"9","author":"Le Poole IC","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref91","article-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang CQ","year":"2011","journal-title":"PLoS One"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang KS","year":"2001","journal-title":"J Invest Dermatol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn JG","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund JJ","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/0008-5472.CAN-03-2828","article-title":"Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells","volume":"64","author":"Lengagne R","year":"2004","journal-title":"Cancer Res"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0065-2776(06)90006-6","article-title":"Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo","volume":"90","author":"Uchi H","year":"2006","journal-title":"Adv Immunol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00262-008-0506-5","article-title":"Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients","volume":"58","author":"Jacobs JF","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1600-0749.2003.00038.x","article-title":"Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin?","volume":"16","author":"Wankowicz-Kalinska A","year":"2003","journal-title":"Pigment Cell Res"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1471-4906(00)01844-5","article-title":"A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo","volume":"22","author":"Das PK","year":"2001","journal-title":"Trends Immunol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-07-1264","article-title":"Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor","volume":"67","author":"Zhang P","year":"2007","journal-title":"Cancer Res"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist J","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili Y","year":"2012","journal-title":"PLoS One"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1755-148X.2012.01019.x","article-title":"Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells","volume":"25","author":"Zhou L","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-148X.2011.00920.x","article-title":"Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo","volume":"25","author":"Ben Ahmed M","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1755-148X.2010.00703.x","article-title":"First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi","volume":"23","author":"van Geel NA","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi S","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska A","year":"2003","journal-title":"Lab Invest"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-4632.2006.02744.x","article-title":"Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo","volume":"45","author":"Birol A","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti S","year":"2002","journal-title":"Pigment Cell Res"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2011.07.018","article-title":"Circulatory levels of T-cell cytokines (interleukin [IL]2, IL-4, IL-17, and transforming growth factor-beta) in patients with vitiligo","volume":"66","author":"Khan R","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"ref111","first-page":"407","article-title":"Association of the Kobner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris","volume":"135","author":"Njoo MD","year":"1999","journal-title":"Arch Dermatol"},{"issue":"2","key":"ref112","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1242\/jcs.95.2.263","article-title":"Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion","volume":"95","author":"Lightner VA","year":"1990","journal-title":"J Cell Sci"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2133.1997.18011894.x","article-title":"Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion","volume":"137","author":"Le Poole IC","year":"1997","journal-title":"Br J Dermatol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2003.05024.x","article-title":"Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo","volume":"148","author":"Gauthier Y","year":"2003","journal-title":"Br J Dermatol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.200602132","article-title":"CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1","volume":"175","author":"Fukunaga-Kalabis M","year":"2006","journal-title":"J Cell Biol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","article-title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","volume":"144","author":"Jimbow K","year":"2001","journal-title":"Br J Dermatol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter KU","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.0022-202X.2004.22230.x","article-title":"Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress","volume":"122","author":"Hasse S","year":"2004","journal-title":"J Invest Dermatol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02505037","article-title":"Increased monoamine oxidase A activity in the epidermis of patients with vitiligo","volume":"288","author":"Schallreuter KU","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.8128228","article-title":"Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin","volume":"263","author":"Schallreuter KU","year":"1994","journal-title":"Science"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0925-4439(94)90027-2","article-title":"Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo","volume":"1226","author":"Schallreuter KU","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca V","year":"1997","journal-title":"J Invest Dermatol"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/0378-6323.48427","article-title":"Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin","volume":"75","author":"Sravani PV","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0749.1998.tb00714.x","article-title":"Epidermal oxidative stress in vitiligo","volume":"11","author":"Passi S","year":"1998","journal-title":"Pigment Cell Res"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0749.1994.tb00034.x","article-title":"Antioxidant status in the blood of patients with active vitiligo","volume":"7","author":"Picardo M","year":"1994","journal-title":"Pigment Cell Res"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1346-8138.2003.tb00356.x","article-title":"The role of oxidants and antioxidants in generalized vitiligo","volume":"30","author":"Yildirim M","year":"2003","journal-title":"J Dermatol"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000146813","article-title":"Modulation of melanocytic activity by acetylcholine","volume":"136","author":"Iyengar B","year":"1989","journal-title":"Acta Anat (Basel)"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2004.01.082","article-title":"Activation\/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo","volume":"315","author":"Schallreuter KU","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0749.1992.tb00003.x","article-title":"Catecholamines and vitiligo","volume":"5","author":"Morrone A","year":"1992","journal-title":"Pigment Cell Res"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1034\/j.1600-0749.2003.00015.x","article-title":"Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase","volume":"16","author":"Cucchi ML","year":"2003","journal-title":"Pigment Cell Res"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00403-002-0295-1","article-title":"Association between catechol-O-methyltransferase polymorphism and vitiligo","volume":"294","author":"Tursen U","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00403-008-0920-8","article-title":"A functional single-nucleotide polymorphism in the catechol-O-methyltransferase gene alter vitiligo risk in a Chinese population","volume":"301","author":"Li K","year":"2009","journal-title":"Archives of dermatological research"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.gene.6364243","article-title":"A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo","volume":"6","author":"Canton I","year":"2005","journal-title":"Genes Immun"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jdermsci.2007.10.002","article-title":"Association of PTPN22 1858C\/T polymorphism with vitiligo susceptibility in Gujarat population","volume":"49","author":"Laddha NC","year":"2008","journal-title":"J Dermatol Sci"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1755-148X.2008.00443.x","article-title":"The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population","volume":"21","author":"Laberge GS","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/sj.jid.5701233","article-title":"PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not","volume":"128","author":"LaBerge GS","year":"2008","journal-title":"J Invest Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v89n3\/0365-0596-abd-89-03-0461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:42Z","timestamp":1747666842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962014000300461&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0365-05962014000300461"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20142573","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}